| Headquarters: | Frankfurt am Main, Germany |
| Branch Offices: | Germany, Great Britain, France, Italy, Spain, Switzerland, Austria, USA, Mexico, Russia |
| Status: | Private company |
| Fiscal Year: | July 1 - June 30 |
| Key Figures of the Merz Group | ||||
|---|---|---|---|---|
| 2007/08 | 2006/07 | Change in % | ||
| Sales | EUR million | 610.5 |
535.5 |
14.0 |
| of which: | ||||
| Pharmaceuticals | EUR million | 420.8 |
359.4 |
17.1 |
| Consumer Products | EUR million | 116.5 | 110.9 |
5.1 |
| Writing Instruments / Promotional Items | EUR million | 73.2 |
65.2 |
12.4 |
| of which: | ||||
| Germany | EUR million | 197.7 |
184.4 |
7.2 |
| Rest of Europe | EUR million | 198.4 |
163.0 |
21.7 |
| America | EUR million | 199.5 | 177.8 |
12.2 |
| Rest of world | EUR million | 14.9 |
10.3 |
44.7 |
| Performance | ||||
| EBIT | EUR million | 124.2 |
111.6 |
11.3 |
| EBIT-margin | % | 20.3 |
20.8 |
<>|
| Pre-tax profit | EUR million | 128.7 |
115.4 |
11.6 |
| Net profit | EUR million | 90.4 |
70.0 |
29.2 |
| Operating cash flow | EUR million | 133.1 | 121.5 |
9.5 |
| Research and development | ||||
| Research and development expenses | EUR million |
87.1 |
60.1 |
44.9 |
| In % of sales |
% | 14.3 |
11.2 |
<>|
| of which: Pharmaceuticals | EUR million |
84.2 |
57.9 |
45.3 |
| Financial position | ||||
| Investments | EUR million | 33.0 |
28.3 |
16.5 |
| Depreciation and amortization | EUR million | 10.6 |
9.9 |
6.6 |
| Equity | EUR million | 325.2 |
270.1 |
20.4 |
| in % of balance sheet total | % | 67.2 |
63.4 |
<>|
| Balance sheet total | EUR million | 484.0 |
426.0 |
13.6 |
| Employees | ||||
| Number of employees as of balance sheet date | 2,289 |
2,052 |
11.5 |
|
![back to top [link]](skin_img/skin_contentSiteInfo-backToTop-arrow.gif)
Last update: 24 Feb 2009, 03:09
produced by GPM mbH
URL: http://www.merz.com/company/facts_and_figures/
Last update: 24.02.2009, 15:09 Uhr
© 2009 Merz. All rights reserved.